Chapter 4
Breaking Barriers: The Pioneers Who Dared to Touch the Heart
Until the early nineteenth century, the heart was considered surgically untouchable. Aristotle had written that "the heart alone of all the viscera cannot withstand injury," and Galen noted heart wounds in gladiators were invariably fatal. Cardiac wounds were treated with absolute quiet and leeches, resulting in over 90% mortality.
By the late nineteenth century, attitudes began changing. In 1881, surgeon John Bingham Roberts suggested heart wounds might someday be treated surgically. German doctor M. Block demonstrated successful heart suturing in rabbits, while Charles Albert Elsberg's animal experiments showed hearts could withstand more manipulation than previously believed.
Daniel Williams made history in 1893 when he operated on stabbing victim James Cornish, suturing a lacerated artery and the pericardium while noting but leaving alone a clotted wound in the right ventricle. Cornish recovered and walked out of the hospital nearly two months later, ultimately outliving Williams by twelve years.
Though Williams claimed the first successful pericardial suture, Ludwig Rehn performed the first true heart muscle repair in 1896, suturing a ventricle laceration in Wilhelm Justus, a stabbed gardener. At a Berlin surgical meeting, Rehn later declared "the feasibility of cardiac repair no longer remains in doubt," encouraging further exploration of cardiac surgery.
By 1907, Rehn reported 120 heart surgeries worldwide with 40% success-a fourfold improvement over non-surgical treatment. However, the full development of heart surgery would take decades more, as surgeons faced the challenge of isolating and stopping the heart without causing brain damage. The fundamental question remained: could nature's ultimate machine be temporarily replaced by a man-made pump?
The answer would come through the development of the heart-lung machine, described as "among the boldest and most successful feats of man's mind." Conceived by John Gibbon in 1930, it took nearly twenty-five years to develop, delayed by economic depression, world war, and cultural resistance to mechanically replacing "the organ that houses the soul."
Without such a machine, cardiac surgeons faced an impossible dilemma: once the heart is stopped, the brain suffers irreversible damage after just 3-5 minutes without oxygen, yet most heart repairs require at least 10 minutes to complete.
Chapter 5
Ingenious Solutions: Cross-Circulation and the Heart-Lung Machine
C. Walton Lillehei, perhaps the most innovative surgeon of the twentieth century, believed there was an alternative to the heart-lung machine. A cancer survivor with a 25% chance of living five years, Lillehei approached death with unusual courage that fueled his surgical innovations.
In his modest attic lab at the University of Minnesota, Lillehei developed "controlled cross-circulation"-inspired by mother-fetus circulation. He connected two anesthetized dogs through a milk pump that pushed equal amounts of blood between them, allowing one dog to serve as heart and lungs for the other while its heart was stopped for surgery. After successful animal trials, Lillehei sought to apply this bizarre but ingenious technique to humans with congenital heart defects-a proposal that shocked his colleagues as the first operation with potential to kill two people.
Lillehei's first human cross-circulation patient was thirteen-month-old Gregory Glidden, whose older sister had died from the same ventricular septal defect. Using the boy's father as a donor, Lillehei connected them via a beer hose and milk pump, with the father's heart and lungs keeping both alive while Lillehei repaired the dime-sized hole in Gregory's heart. Though Gregory died eleven days later from pneumonia, his VSD remained closed.
Undeterred, Lillehei continued using cross-circulation with some success, though a streak of deaths and complications-including a donor mother suffering brain damage-led to criticism. He eventually abandoned the technique after performing forty-five operations with twenty-eight survivors, a 40% mortality rate that was still better than the natural prognosis for uncorrected defects.
Meanwhile, John Gibbon partnered with IBM to scale his heart-lung machine for humans, solving problems like blood cell damage and clotting. Despite seventeen failures across various centers attempting similar technology, Gibbon achieved the first success in 1953 with eighteen-year-old Cecelia Bavolek, repairing her atrial septal defect during 30 minutes of machine-supported circulation.
Today's compact heart-lung machines enable over one million cardiac operations annually worldwide. The invention revolutionized cardiac surgery, dropping mortality rates from 50% to 10% within just two years, making even complex congenital defects routinely repairable.
Chapter 6
Exploring the Heart's Highways: Coronary Interventions
The question of why coronary artery disease develops vexed mid-century scientists even as treatments advanced. The Framingham Heart Study, begun shortly after World War II in Massachusetts, would provide crucial answers and almost single-handedly define modern heart disease science. This groundbreaking longitudinal study, launched in 1948, selected the town of Framingham for its stable population and proximity to Boston's medical facilities.
The study emerged from necessity-cardiovascular disease caused nearly half of all U.S. deaths in the 1940s, yet medical understanding was minimal. Doctors didn't even know that myocardial infarction resulted from coronary artery obstruction. This ignorance claimed many victims, including President Franklin Roosevelt, whose untreated hypertension reached life-threatening levels before his death from stroke in 1945 at age 63. His blood pressure had soared to 300/190 mmHg, yet contemporary medical wisdom considered hypertension necessary to push blood through aging arteries.
After ten years of monitoring 5,200 patients through detailed examinations, blood tests, and electrocardiograms, researchers published landmark findings in 1957 showing hypertension increased coronary heart disease risk nearly fourfold. Subsequent publications identified additional risk factors including diabetes, high cholesterol, and smoking. The study revealed that men with cholesterol levels above 245 mg/dL had three times the risk of heart disease. Framingham introduced the term "risk factor" in 1961 and later developed a formula to calculate ten-year heart disease risk, revolutionizing preventive cardiology.
While scientists understood disease mechanisms, visualizing coronary blockages remained challenging until 1958, when Mason Sones accidentally discovered coronary angiography when his catheter slipped into a patient's right coronary artery at Cleveland Clinic. Initially terrified he'd killed his patient, Sones instead witnessed the first clear images of coronary arteries in a living person. This breakthrough allowed physicians to pinpoint coronary blockages using dye and X-rays, though developing treatments would take another two decades.
Charles Dotter, an eccentric radiologist nicknamed "Crazy Charlie" for his unconventional approaches, pioneered angioplasty in 1964 on Laura Shaw, an 82-year-old with a blocked leg artery facing amputation. Using a series of progressively larger catheters, he successfully reopened her artery, and she walked out of the hospital on her own feet. Despite widespread publicity, including features in Time and Life magazines, Dotter faced fierce criticism from conservative colleagues, being called "a nut" with "poorly documented case experience."
Andreas Gruentzig refined Dotter's technique by adding an inflatable balloon to the catheter, a breakthrough inspired by a latex balloon he saw at a toy store. After extensive testing on dogs and cadavers, Gruentzig performed the first human balloon angioplasty in 1974 in Zurich, and the first coronary angioplasty in 1977. His patient, Adolph Bachmann, lived for another 30 years after the procedure. Today, several million angioplasties are performed worldwide yearly, with most using drug-coated stents to prevent restenosis, achieving success rates above 90% in appropriate candidates.
Chapter 7
The Heart's Electrical Symphony: Rhythm and Disruption
The heart functions fundamentally as an electrical organ, with each of its three billion lifetime beats beginning in the sinoatrial node-the natural pacemaker. Electrical impulses travel through specialized conductive tissue, slowing at the atrioventricular node before branching through the ventricles like tree roots. This coordinated electrical activity causes near-simultaneous ventricular contraction, pumping blood to the lungs and body.
George Mines, a Cambridge-educated physiologist and former piano prodigy, made two fundamental discoveries in cardiac electrophysiology. First, he identified that small electrical channels outside normal conduction pathways could create self-sustaining circuits-a phenomenon he called "reentry." If one side of such a circuit recovers excitability before an impulse completes its journey, the impulse can circulate indefinitely, usurping the heart's natural pacemaker.
Mines also discovered the "vulnerable period"-a brief 10-millisecond window during each cardiac cycle when even a normal heart can be triggered into fibrillation-explaining why healthy athletes can die from chest impacts. Tragically, Mines died in 1914 at age 28, likely from self-experimentation on the vulnerable period.
Ventricular fibrillation-the most common cause of cardiovascular death in the Western world-occurs when rapid, chaotic electrical impulses cause the heart to quiver ineffectively rather than pump. Though blood flow essentially stops, the heart continues its violent, uncoordinated contractions.
Following Mines's work, researchers explored using man-made electricity to control failing hearts. Paul Zoll developed external pacing for complete heart block in the postwar years. The revolutionary concept of implantable pacemakers emerged from Walt Lillehei's team at the University of Minnesota, with the first successful implant in a six-year-old girl in January 1957.
A long-term solution emerged when Wilson Greatbatch accidentally installed the wrong resistor in a circuit, creating a pulse that mimicked the human heartbeat. Working with surgeon William Chardack, Greatbatch developed the first implantable pacemaker, successfully tested in humans in 1960.
The implantable defibrillator came from Michel Mirowski, a Holocaust survivor whose close friend died of ventricular tachycardia. Despite rejection from medical journals and manufacturers, Mirowski persisted. The FDA approved his device in 1985, paving the way for countless patients to benefit from this life-saving technology.
Chapter 8
When Hearts Fail: Transplantation and Artificial Hearts
Heart failure represents the final common pathway for many cardiac diseases, where damaged heart muscle leads to weakened contractions and reduced blood flow. The body compensates by releasing hormones that increase heart rate and cause the kidneys to retain water, temporarily maintaining blood pressure but ultimately causing fluid to accumulate throughout the body. Half of heart failure patients die within five years of diagnosis.
Heart transplantation offers the definitive treatment, with modern survival rates reaching 85% at one year-four times better than medication alone. By the 1960s, pioneering surgeons Christiaan Barnard and Norman Shumway were racing to perform the first human heart transplant. Barnard won on December 3, 1967, when his patient, Louis Washkansky, received a heart from a young woman with brain damage from a car accident. Though Washkansky survived only eighteen days, the procedure demonstrated feasibility.
Today, heart transplantation boasts excellent outcomes with median survival exceeding twelve years. Yet this success is bittersweet-only about 3,000 Americans receive transplants annually while 4,000 wait on the list and perhaps 40,000 could benefit. As Vanderbilt cardiologist Lynne Warner Stevenson put it, "Relying on transplants to cure heart failure is a bit like relying on the lottery to cure poverty."
For half a century, creating a mechanical replacement heart has been cardiology's great ambition. The first permanent artificial heart was implanted in Barney Clark on December 2, 1982. Clark received the Jarvik-7, an aluminum-and-plastic heart powered by a 400-pound air compressor. Though he survived 112 days, his course was plagued by complications including seizures, respiratory failure, kidney failure, and infections.
Today's most advanced model, CardioWest, has supported nearly a hundred patients, with the record holder surviving 1,373 days before successful transplantation. For most heart failure patients today, left-ventricular assist devices (LVADs) have become the preferred mechanical support, pumping blood directly from the left ventricle to the aorta. However, for patients with failure of both ventricles, a permanent artificial heart remains the only option-still more dream than reality, but no longer the pipe dream it was in 1982.
Chapter 9
The Vulnerable Heart: Emotions and Cardiac Health
The profound connection between psychological trauma and heart rhythm disturbances represents a crucial frontier in cardiovascular medicine. Bernard Lown's groundbreaking research definitively demonstrated that psychological stress could trigger dangerous arrhythmias. Working with psychiatrists, Lown's team discovered that nearly 20% of sudden arrhythmia survivors had experienced acute psychological stress within 24 hours before their attacks. These triggering events included public humiliation, marital separation, bereavement, or business failure - highlighting how deeply emotional trauma can impact cardiac function. Further studies revealed that even anticipated stress, such as upcoming public speaking events or important meetings, could create dangerous cardiac conditions.
The relationship between psychological trauma and arrhythmias operates as a two-way street, creating a complex feedback loop between mind and heart. Patients with implantable defibrillators often develop debilitating anxiety after experiencing shocks, with many developing post-traumatic stress symptoms that dramatically impact their quality of life. These manifestations include stopping driving, avoiding leaving home, and experiencing significant weight loss due to stress-induced appetite changes. One patient vividly described the shocks as "like a donkey rearing his hind legs and hitting you right in the chest with full force." Medical professionals have observed that this anxiety can itself trigger additional arrhythmias, perpetuating a vicious cycle of physical and emotional distress.
Research into sleep patterns has revealed another surprising connection: intense dreams can trigger sudden cardiac death, with 12 percent of cardiovascular deaths occurring during sleep. During REM sleep, surges of adrenaline can create a perfect storm of cardiac risk factors - disrupting atherosclerotic plaque, stimulating blood clotting, causing coronary spasm, and triggering ventricular arrhythmias. Heart rate may spike dramatically from 50 to 170 beats per minute during nightmares, placing significant stress on vulnerable cardiac tissue. This finding has led to increased attention to sleep disorders in cardiac patients.
While cardiology has achieved remarkable technological advances over the past fifty years - including sophisticated pacemakers, implantable defibrillators, refined angioplasty techniques, improved bypass surgery, and successful heart transplantation programs - which have contributed to a 60 percent drop in cardiovascular mortality since 1968, progress has recently slowed significantly. The decline in cardiovascular mortality has plateaued due to multiple factors: smoking rates have leveled off after decades of decline, obesity rates continue to climb dramatically, and diabetes cases surge across all demographic groups. These trends suggest that technological solutions alone cannot address the full spectrum of cardiovascular health challenges.
The author advocates for a fundamental paradigm shift in cardiovascular medicine, emphasizing prevention over technological solutions. This new approach must acknowledge that heart disease has deep psychological, social, and political roots that extend far beyond traditional medical boundaries. Effective intervention requires a holistic strategy that addresses lifestyle factors, emotional well-being, social support systems, and broader public health initiatives. This might include stress reduction programs, psychological support for cardiac patients, community-based prevention efforts, and policy changes to promote heart-healthy environments. The future of cardiovascular health depends on recognizing and addressing these complex interconnections between mind, body, and society.
Chapter 10
Finding Balance: The Personal Heart Journey
After discovering his own coronary blockages through a CT scan, Jauhar faces his own mortality. He's experienced premature ventricular contractions for years-a mostly benign condition causing heart flutters followed by a "compensatory pause." Additional tests reveal normal heart function but elevated lipoprotein(a), which more than doubles the risk of coronary disease. As a South Asian, he faces additional risk factors including smaller coronary arteries, denser cholesterol particles, and possibly "thrifty genes" that create abdominal fat when exposed to Western lifestyles.
Determined not to let his scan dictate his fate, Jauhar seeks fundamental life changes beyond his already healthy habits and statin medication. He visits his friend Anand at a Hindu temple, who advises him to "get out of your mind" through yoga and meditation. "Your mind, your thoughts, are not your owner, but they are behaving as your owner. Go beyond mind. That is the only place you are truly free."
Jauhar explores Dean Ornish's cardiac rehabilitation program, which combines a low-fat vegetarian diet, exercise, stress management, and group support. The program coordinator believes "the social support and stress management are probably the most important pieces." Studies support this view-depressed heart attack patients were four times likelier to die within six months, while hopeless menopausal women showed more arterial thickening.
Ultimately, Jauhar makes sustainable changes-exercising daily, eating better, spending more time with family and friends, and no longer being "contemptuous of relaxation." At forty-eight, he acknowledges the privileges of modern cardiology that his grandfather, who died in his early fifties, didn't have. Yet beyond technological interventions, he recognizes that emotional well-being is equally crucial for heart health.
"Your mind-set, your coping strategies, how you navigate challenging circumstances, your capacity to transcend distress, your capacity to love-these things, I believe, are also a matter of life and death." The heart remains both a machine to be repaired and the metaphorical seat of our emotional lives-a duality that makes cardiology not just a medical specialty but a profound exploration of what makes us human.
